×
Log in
Upload File
Most Popular
Study
Business
Design
Technology
Travel
Explore all categories
The top documents tagged [placebo p]
Herbs and Supplements for GI Disorders Kathi J. Kemper, MD Caryl J Guth Chair for Holistic and Integrative Medicine Professor, Pediatrics, Public Health
215 views
The Tilarginine Acetate Injection in a Randomized International Study in Unstable Acute Myocardial Infarction Patients with Cardiogenic Shock (TRIUMPH)
216 views
Dietary Supplements and Diabetes: What’s New? Laura Shane-McWhorter, PharmD, BCPS, BC-ADM, CDE, FASCP, FAADE University of Utah College of Pharmacy 1
229 views
Milk Thistle Botany –Silybum marianum –Asteraceae family (daisy, thistles, artichoke) History –long used to treat “liver problems Chemistry – fruits/seeds
230 views
Downloaded from Slide 1 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy
222 views
TM © 1999 Professional Postgraduate Services ® Perspectives on Lipid-Lowering Therapy With HMG-CoA Reductase Inhibitors
217 views
Omega-3 PUFA and Cardiac Arrhythmias Dalit Weisman R.D, Msc, PhD student Electrophysiology Unit Heart Institute Sheba Medical Center
224 views
Luveris ® New Drug Application (21-322 ) Kate Meaker, M.S. Statistical Reviewer Division of Biometrics II Kate Meaker, M.S. Statistical Reviewer Division
217 views
Relevance of AT 1 blockade. Adapted from McConnaughey et al. J Clin Phamacol 1999;39: 547–59. Angiotensin II AT 1 Receptor AT 2 Receptor -sartan Angiotensin
217 views
Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium to Prevent Oxaliplatin- Induced Sensory Neurotoxicity, N08CB
225 views
Slide 1 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist Losartan
219 views
ESC Congress 2008 Clinical Trial Summary Slides. 3T/2R Troponin I or T >3x ULN at 48 hours: 20% for tirofiban vs. 35% for placebo (p = 0.009) MACE at
213 views
< Prev
Next >